Efficacy of Point Of Service Testing in MBC

Description

This study will assess the efficacy of an innovative point of service cancer genetics counseling delivery model for metastatic breast cancer (MBC) patients whom have received a referral for hereditary cancer genetic counseling and testing.

Conditions

Metastatic Cancer, Breast Cancer

Talk to us

Study Overview

On this page

Study Details

Study overview

This study will assess the efficacy of an innovative point of service cancer genetics counseling delivery model for metastatic breast cancer (MBC) patients whom have received a referral for hereditary cancer genetic counseling and testing.

Efficacy of Point Of Service Testing in Metastatic Breast Cancer

Efficacy of Point Of Service Testing in MBC

Condition
Metastatic Cancer
Intervention / Treatment

-

Contacts and Locations

Kansas City

The University of Kansas Cancer Center, Westwood Campus, Kansas City, Kansas, United States, 66205

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Ability of participant OR Legally Authorized Representative (LAR) to understand this study, and participant or LAR willingness to sign a written informed consent.
  • * Able to speak and read in the English language.
  • * Have a diagnosis of human epidermal growth factor receptor 2 (HER2) negative metastatic breast cancer.
  • * Participants must be enrolled in the parent registry study.
  • * Genetic testing for a breast cancer gene (BRCA) BRCA1 and BRCA2 mutation completed after 2013 or any BRCA 1 and BRCA2 testing with large rearrangement testing. Prior genetic counseling is allowed.
  • * Psychiatric illness/social situations that would limit compliance with study requirements.

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

University of Kansas Medical Center,

Lauren Nye, MD, PRINCIPAL_INVESTIGATOR, University of Kansas

Study Record Dates

2025-08